Evidence brief · printable

Peripheral Arterial Disease evidence brief

One page, every section sourced. Print it or bring it on your phone.

  1. Research Tracker
  2. Evidence briefs
  3. Peripheral Arterial Disease

Print or save as PDF Fits on one A4 or Letter page.

Peripheral Arterial Disease: evidence brief

Open Source Medicine Foundation · page built 16 November 2026 · trial data searched 2026-11-16 (capped at 1,000 of 1,163 matching trials) · https://research.opensourcemed.info/briefs/peripheral-arterial-disease.html

Research information, not medical advice. Prepared to support a conversation with a clinician, not to choose a treatment.

Live version

Medicines with registered trials

Scale: trials listed for each medicine on the tracker's condition page, a snapshot of ClinicalTrials.gov. A trial means it is being studied, not that it works.

  • CD34-positive cells 2 trials
  • Gadopentetate dimeglumine (Magnevist, BAY86-4882) 2 trials
  • Alirocumab 1 trial
  • Angiotensin II type 1 receptor antagonists 1 trial
  • Ankle-Brachial Index (ABI) 1 trial
  • ARB (Telmisartan) 1 trial

Non-drug approaches tested

Scale: trial status on ClinicalTrials.gov (completed, results posted). Status is not a result.

  • Shock-wave and vibration therapy 8 trials · 6 completed · 5 with results
  • Aerobic and endurance exercise 30 trials · 17 completed · 4 with results
  • Peripheral electrical and electromagnetic stimulation 16 trials · 9 completed · 4 with results
  • Education, coaching and self-management 14 trials · 8 completed · 4 with results
  • Heat, cold and water therapies 6 trials · 3 completed · 3 with results
  • Nutrition counselling and food-based products 5 trials · 2 completed · 1 with results

Natural products (RepurpOS Moderate tier)

Scale: RepurpOS evidence tier, from linked trials and literature. Product quality and dose vary.

  • Ginkgo Biloba
  • Omega-3 Fatty Acids
  • L-Arginine
  • Alpha-Lipoic Acid
  • L-Carnitine
  • Resveratrol

Trials recruiting

Status as recorded on ClinicalTrials.gov when searched (2026-11-16); check the registry for current status and eligibility.

  • Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants… NCT07318610
  • Improving Mobility After Revascularization in Peripheral Artery Disease NCT06686121
  • Personalizing Thromboprophylaxis for Patients With Peripheral Artery Disease NCT07613840
  • Examining the Impact of Exercise Training on Vascular Dysfunction in Individuals… NCT04916327
  • Randomized Controlled Trial of Alert-Based Computerized Decision Support for… NCT06300450
  • Improving Mobility After Revascularization in Peripheral Artery Disease NCT06686121

What we don't know yet

Gaps in registered trials, from the evidence-gap map. A gap is not a recommendation.

  • Exercise and physical activity: quality of life 10 trials, no results posted yet
  • Rehabilitation and therapy services: physical function and exercise capacity 10 trials, no results posted yet
Sources: ClinicalTrials.gov (trials, status, posted results); RepurpOS natural-product tiers (registry trials, PubMed, reference databases); OSMF biomarker atlas where available; OSMF non-drug evidence map (219 non-drug trials for this condition). Lists are shortened; the live pages carry every entry with its source: evidence-gap map · RepurpOS · condition page. Counts change daily. Nothing here is a recommendation to start, stop or change any treatment.